Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

343 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. Snape MD, et al. Among authors: dobson s. JAMA. 2008 Jan 9;299(2):173-84. doi: 10.1001/jama.2007.29-c. JAMA. 2008. PMID: 18182599 Clinical Trial.
Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.
Booy R, Taylor SA, Dobson SR, Isaacs D, Sleight G, Aitken S, Griffiths H, Chapel H, Mayon-White RT, Macfarlane JA, et al. Booy R, et al. Among authors: dobson sr. Arch Dis Child. 1992 Apr;67(4):475-8. doi: 10.1136/adc.67.4.475. Arch Dis Child. 1992. PMID: 1580674 Free PMC article.
Assessment of a universal, school-based hepatitis B vaccination program.
Dobson S, Scheifele D, Bell A. Dobson S, et al. JAMA. 1995 Oct 18;274(15):1209-13. JAMA. 1995. PMID: 7563510
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. Perrett KP, et al. Among authors: dobson s. Pediatr Infect Dis J. 2009 Mar;28(3):186-93. doi: 10.1097/INF.0b013e31818e037d. Pediatr Infect Dis J. 2009. PMID: 19209097 Clinical Trial.
Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.
Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, Li Y, Law B, Halperin SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Rapid Trials Investigators. Scheifele DW, et al. Among authors: dobson s. Pediatr Infect Dis J. 2011 May;30(5):402-7. doi: 10.1097/INF.0b013e3182068f33. Pediatr Infect Dis J. 2011. PMID: 21178654
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
Khatami A, Snape MD, Davis E, Layton H, John T, Yu LM, Dull PM, Gill CJ, Odrjlin T, Dobson S, Halperin SA, Langley JM, McNeil SA, Pollard AJ. Khatami A, et al. Among authors: dobson s. Vaccine. 2012 Apr 16;30(18):2831-8. doi: 10.1016/j.vaccine.2012.02.046. Epub 2012 Mar 3. Vaccine. 2012. PMID: 22394992
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, Langley JM, Bettinger JA, Singer J, Money D, Miller D, Naus M, Marra F, Young E. Dobson SR, et al. JAMA. 2013 May 1;309(17):1793-802. doi: 10.1001/jama.2013.1625. JAMA. 2013. PMID: 23632723 Clinical Trial.
Association Between Antibiotic Use and Neonatal Mortality and Morbidities in Very Low-Birth-Weight Infants Without Culture-Proven Sepsis or Necrotizing Enterocolitis.
Ting JY, Synnes A, Roberts A, Deshpandey A, Dow K, Yoon EW, Lee KS, Dobson S, Lee SK, Shah PS; Canadian Neonatal Network Investigators. Ting JY, et al. Among authors: dobson s. JAMA Pediatr. 2016 Dec 1;170(12):1181-1187. doi: 10.1001/jamapediatrics.2016.2132. JAMA Pediatr. 2016. PMID: 27775765
Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months.
Ogilvie G, Sauvageau C, Dionne M, McNeil S, Krajden M, Money D, Dobson S. Ogilvie G, et al. Among authors: dobson s. JAMA. 2017 Apr 25;317(16):1687-1688. doi: 10.1001/jama.2017.1840. JAMA. 2017. PMID: 28444267 Clinical Trial. No abstract available.
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
Halperin SA, Langley JM, Ye L, MacKinnon-Cameron D, Elsherif M, Allen VM, Smith B, Halperin BA, McNeil SA, Vanderkooi OG, Dwinnell S, Wilson RD, Tapiero B, Boucher M, Le Saux N, Gruslin A, Vaudry W, Chandra S, Dobson S, Money D. Halperin SA, et al. Among authors: dobson s. Clin Infect Dis. 2018 Sep 14;67(7):1063-1071. doi: 10.1093/cid/ciy244. Clin Infect Dis. 2018. PMID: 30010773 Clinical Trial.
METHODS: In a randomized, controlled, observer-blind, multicenter clinical trial, we measured the safety and immunogenicity of Tdap during pregnancy and the effect on the infant's immune response to primary vaccination at 2, 4, and 6 months and booster vaccination at 12 mo …
METHODS: In a randomized, controlled, observer-blind, multicenter clinical trial, we measured the safety and immunogenicity of Tdap during p …
343 results
Jump to page
Feedback